Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57 | 515 | 351 | 1,350 | 2,793 |
| Receivables | 97 | 61 | 73 | 61 | 150 |
| TOTAL | $214 | $639 | $531 | $1,496 | $3,435 |
| Non-Current Assets | |||||
| PPE Net | 264 | 294 | 100 | 53 | 59 |
| Intangibles | 0 | 35 | 38 | 38 | 39 |
| TOTAL | $264 | $329 | $138 | $92 | $98 |
| Total Assets | $478 | $968 | $669 | $1,588 | $3,533 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,711 | 1,560 | 1,467 | N/A | N/A |
| TOTAL | $4,054 | $3,250 | $2,942 | $391 | $220 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 1,638 | 1,746 |
| TOTAL | $8 | $15 | $23 | $1,638 | $1,746 |
| Total Liabilities | $4,062 | $3,266 | $2,964 | $2,029 | $1,967 |
| Shareholders' Equity | |||||
| Common Shares | 19,242 | 19,144 | 17,897 | 17,152 | 16,951 |
| Retained earnings | -29,808 | -28,460 | -27,281 | -19,104 | -16,907 |
| Other shareholders' equity | 6,981 | 7,019 | 7,088 | 1,511 | 1,522 |
| TOTAL | $-3,584 | $-2,297 | $-2,295 | $-442 | $1,566 |
| Total Liabilities And Equity | $478 | $968 | $669 | $1,588 | $3,533 |